All News #Library
Others
FDA Issues Untitled Letter to Althera for Statements Relating to ROSZET
24 Jun 2022 //
LEXBLOG
FDA slams Althera for misleading ad with dearth of safety info & dubious stats
08 Jun 2022 //
ENDPTS

Market Place
Sourcing Support